Home » Newsletters » BioWorld

BioWorld

Oct. 17, 2001

View Archived Issues

Appointments And Advancements

Organogenesis Completes Financings Totaling $20.25M

D-Pharm Raises $30M In Series D To Advance Drugs

Lilly 'Shocked' By Panel Vote; Sepsis Remains Elusive Target

AnorMED Reports Positive Phase III Results For Foznol

In Breast Cancer, Animals With, Without Thrombospondin Show Angiogenesis Inhibitor Potential

Transforming Alkermes Signs Deal For Delivery With Bioject

Other News To Note